ABCC1 and small cell lung carcinoma: MK571, a CysLT1R antagonist, modulated MRP-associated multidrug resistance in HL60/AR and GLC4/ADR cells, MRP-overexpressing multidrug resistant human leukemia and human small cell lung cancer cell lines, respectively, in a dose-dependent manner [83].